New project launched to accelerate development and accessibility of H5N1 mRNA vaccine candidates

FHS
July 29, 2024
11:22 am

A new project aiming to accelerate the development and accessibility of human avian influenza (H5N1) messenger RNA (mRNA) vaccine candidates for manufacturers in low- and middle-income countries has been launched today.

Zimmer Biomet promotes 3 executives

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Name: Mark Bezjak New title: President of

September 7, 2023

Eli Lilly supports Alto Neuroscience in $45m Series C round – Pharmaceutical Technology

Share this article The company’s candidates ALTO-100, ALTO-202 and ALTO-300 are all developed for depression, with ALTO-100 also being developed for post-traumatic stress disorder. Image

November 22, 2023

Immunic Presents Data From Phase 1b Clinical Trial of IMU-856 in Celiac Disease at the United European Gastroenterology Week 2023 – Biotech Investments

Issuer: Immunic, Inc. / Key word(s): Conference/Study results 15.10.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic Presents

October 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.